Unveiling the hidden role of SDHA in breast cancer proliferation: a novel therapeutic avenue

被引:0
|
作者
Yong, Liyun [1 ]
Fang, Yuan [1 ]
Jin, Lingli [1 ]
Zhang, Xiuqin [2 ]
Luis, Manuel A. [1 ]
Lin, Xiaoyan [3 ]
Tang, Shasha [1 ]
Cai, Fengfeng [1 ]
机构
[1] Tongji Univ, Tongji Hosp, Sch Med, Dept Breast Surg, 389 Xincun Rd, Shanghai 200065, Peoples R China
[2] Tongji Univ, Tongji Hosp, Sch Med, Dept Pathol, 389 Xincun Rd, Shanghai 200065, Peoples R China
[3] Tongji Univ, Yangpu Hosp, Sch Med, Dept Breast Surg, Shanghai 200090, Peoples R China
关键词
Breast cancer; SDHA; Prognosis; Proliferation; Migration; MITOCHONDRIAL COMPLEX II; SUCCINATE-DEHYDROGENASE; GENE-MUTATIONS; HETEROGENEITY; EXPRESSION; BIOMARKERS; CELLS;
D O I
10.1186/s12935-025-03746-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundWe observed an increased presence of succinate dehydrogenase complex subunit A (SDHA), a mitochondrial enzyme, in breast cancer (BC), which contributes to its proliferation. While SDHA deficiency has been extensively researched in rare disorders, the upregulation of SDHA and its impact on BC remain understudied. The aim of this study is to investigate the role of SDHA in BC.MethodsThe mRNA expression of SDHA was analyzed from TCGA, clinical BC tissues and various BC cell lines via qPCR. Immunohistochemistry was also applied to detect the SDHA expression. Our study investigated the functional outcomes of SDHA overexpression and knockdown in BC utilizing clinical BC tissues from patients and various BC cell lines (MDA-MB-453, MDA-MB-468, SKBR3, and MCF-7). Multiple web platforms and software tools, including R, HPA and TISIDB, were employed to perform comprehensive data analysis. SDHA overexpression and siSDHA were transiently transfected into the cancer cells separately to assess expression levels, cellular proliferation, and migration dynamics through colony formation assay, CCK8 assay, wound-healing analysis.ResultsWe found that the mRNA expression level of SDHA was higher in cancer tissues or cells than in non-cancerous tissues or mammary epithelial cell in TCGA dataset, BC clinical specimens and BC cell lines, respectively. High SDHA expression was associated with poor overall survival (OS, p = 0.016) and disease specific survival (DSS, p = 0.024) in BC patients. Besides, our findings revealed MDA-MB-468, SKBR3 and MCF-7 cells transfected with siSDHA exhibited significantly reduced proliferation and migration capabilities. Conversely, the proliferation and migration abilities of these BC cells significantly increased when transfected with SDHA overexpression.ConclusionsIn conclusion, this study highlights the previously underestimated role of SDHA in BC proliferation, presenting a novel avenue for therapeutic intervention.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
    Kao, Aaron T.
    V. Cabanlong, Christian
    Padilla, Kendra
    Xue, Xiang
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (09) : 3785 - 3801
  • [2] Modulation of alternative splicing as a novel therapeutic avenue in cancer
    Star, E.
    Mavrou, A.
    Li, L.
    Oltean, S.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S57 - S57
  • [3] Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer
    Balkrishna, Acharya
    Mittal, Rashmi
    Arya, Vedpriya
    CURRENT CANCER DRUG TARGETS, 2021, 21 (11) : 907 - 918
  • [4] Novel therapeutic approaches targeting cancer stem cells: Unveiling new frontiers in breast cancer treatment
    Deeptha, T. C.
    Nabeela, N. K.
    Pushparaj, Charumathi
    Narayanasamy, Arul
    Manickam, Paulpandi
    Thiruvenkataswamy, Saranya
    Sennimalai, Ramya
    PATHOLOGY RESEARCH AND PRACTICE, 2025, 266
  • [5] MARANTIC ENDOCARDITIS AND CANCER: UNVEILING HIDDEN MALIGNANCIES AND THE ROLE OF ANTICOAGULANTS
    Nazarenko, Natalia
    Rubinstein, Gal
    Maliha, Maisha
    Singh, Nikita
    Borkowski, Pawel
    Alhuarrat, Majd Al Deen
    Garg, Vibhor
    Alhuarrat, Mohammad Rasoul
    Faillace, Robert T.
    Palaiodimos, Leonidas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2175 - 2175
  • [6] Unveiling the role of SYNGR4 in breast cancer development: a novel target for immunotherapy
    Ma, Jie
    Wang, Hongtao
    Gui, Zhengwei
    Yang, Yuanrong
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [7] The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target
    Ma, Zhongliang
    Song, Jinlian
    Hua, Yanan
    Wang, Yu
    Cao, Weihong
    Wang, Haibo
    Hou, Lin
    CELL BIOLOGY INTERNATIONAL, 2023, 47 (01) : 283 - 291
  • [8] Breast Cancer: Novel Therapeutic Targets
    Yip, George W.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (02) : 164 - 165
  • [9] Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue
    Prabhu, Lakshmi
    Martin, Matthew
    Chen, Lan
    Demir, Ozlem
    Jin, Jiamin
    Huang, Xiumei
    Motolani, Aishat
    Sun, Mengyao
    Jiang, Guanglong
    Nakshatri, Harikrishna
    Fishel, Melissa L.
    Sun, Steven
    Safa, Ahmad
    Amaro, Rommie E.
    Kelley, Mark R.
    Liu, Yunlong
    Zhang, Zhong-Yin
    Lu, Tao
    GENES & DISEASES, 2023, 10 (01) : 267 - 283
  • [10] Role of Novel Therapeutic Agents in Modulating Invadopodia Formation in Metastatic Breast Cancer
    Harun, Siti Nor Aini
    Abdullah, Nurul Akmaryanti
    Zakuan, Noraina Muhamad
    Hamid, Hafizah Abdul
    Mehat, Muhammad Zulfadli
    Hashim, Nur Fariesha Md
    SAINS MALAYSIANA, 2020, 49 (06): : 1351 - 1358